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Heat shock...what we experience when 
we take a break from writing this com-
mentary and step outdoors into the 
100 degree heat and 100% humidity 
that characterizes this particular North 
Carolina day in the in the middle of 
August. Heat shock...what a bacterium 
experiences when it is shifted from 37 
to 42 oC. It is under the latter conditions 
that the biology of heat shock proteins 
was first described. This family of pro-
teins, including the small heat shock 
protein 27 (HSP27), is induced when 
bacteria are subjected to thermal stress, 
or “heat shock.” HSP27 is so named 
because of the aforementioned property 
and its migration as a protein of molecu-
lar weight 27,000 on SDS-PAGE.
Subsequent to its identification as a 
molecular chaperone that facilitates the 
refolding of heat denatured proteins after 
a thermal stress, HSP27 has been shown 
to have other functions, including roles 
in cell signaling, regulation of the actin 
and intermediate filament cytoskeletons, 
and a potential role in the mechanism of 
pemphigus IgG-induced acantholysis. 
In its role as a chaperone, HSP27 forms 
large oligomeric structures of molecular 
weight up to 800,000, which serve as 
an interface upon which denatured pro-
teins can sample different conformations 
as they find a local free energy minima 
and fold to reform their native structures. 
HSP27 has several phosphorylation sites, 
including ser-15, ser-78, and ser-82. 
Upon phosphorylation, large HSP27 
oligomers dissociate into smaller dim-
ers and tetramers, which regulate various 
cellular processes, including organiza-
tion of the cytoskeleton (Benndorf et al., 
1994; Geum et al., 2002; Panasenko et 
al., 2003; Perng et al., 1999), differen-
tiation (Duverger et al., 2004), and tran-
scriptional activity (Chen et al., 2003; 
Miller et al., 2005).
HSP27 has been implicated in a vari-
ety of pathological processes. For exam-
ple, one variant of Charcot–Marie–Tooth 
disease, in which abnormal aggregation 
of neurofilaments results in neurodegen-
eration, is caused by mutations in HSP27 
(Evgrafov et al., 2004). In the autoim-
mune blistering diseases pemphigus 
vulgaris and pemphigus foliaceus, anti-
desmoglein-3 and anti-desmoglein-1 
autoantibodies, respectively, activate 
intracellular signaling pathways, includ-
ing the p38 MAPK–MAPKAP2–HSP27 
signaling axis (Berkowitz et al., 2005). In 
pemphigus, phosphorylation of HSP27 
has been suggested to be one mecha-
nism by which pathogenic IgG induces 
keratin intermediate filament collapse 
and actin reorganization in the target 
keratinocytes; inhibition of this signal-
ing cascade with p38 inhibitors prevents 
pemphigus IgG-induced cytoskeletal 
changes and blistering in vivo (Berkowitz 
et al., 2008; Berkowitz et al., 2006; Lee 
et al., 2009). Additional roles for HSP27 
include transcriptional regulation. For 
example, HSP27 has been shown to 
bind to estrogen receptors and to down-
regulate estrogen response element tran-
scriptional activity (Chen et al., 2003; 
Miller et al., 2005). HSP27 has also been 
shown to interact directly with, and 
thereby to regulate, p53 transcriptional 
activity (Venkatakrishnan et al., 2008). 
MK2 (MAPKAP2) is likely the major 
HSP27 kinase during stress response, 
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What’s in a Name?:  
Heat Shock Protein 27 and 
Keratinocyte Differentiation
Meryem Bektas1 and David S. Rubenstein1,2
In this issue of the Journal, Robitaille and colleagues present data supporting a role 
for the small heat shock protein (HSP) 27 in keratinocyte terminal differentiation. 
This adds to the growing literature implicating HSP27 as a regulator of biologic 
function beyond thermal stress response.
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colleagues (2010, this issue) adds to the 
expanding functional biology of these 
small, perhaps too narrowly named, 
heat shock proteins.
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differentiation. In human skin equivalents, 
formation of the stratum granulosum 
coincided with increased HSP27 and 
increases in the differentiation-associated 
proteins involucrin and dual leucine 
zipper-bearing kinase (DLK). In contrast 
to HSP27 upregulation, phosphoryla-
tion of HSP27 was a late event, observed 
coincident with formation of the cornified 
envelope. Both observations provide fur-
ther support for the association of HSP27 
with terminal differentiation.
Human skin equivalents offer an 
experimental system that can be manip-
ulated by gene knockin or knockdown. 
Using adenovirus to drive overexpres-
sion of DLK in normal human kerati-
nocytes, the increased distribution of 
HSP27 into the detergent insoluble 
cytoskeletal fraction was observed, but 
this phenomenon was not seen in cells 
transfected with kinase inactive DLK, 
indicating that DLK kinase activity is 
required to alter HSP27 subcellular dis-
tribution. In DLK overexpressing HaCat 
cells, knockdown of HSP27 with HSP27 
siRNA was associated with decreased 
amounts of HSP27 in the cytoskel-
etal fraction and decreased amounts 
of involucrin; the authors interpreted 
this to support an association between 
DLK-regulated HSP27 and terminal dif-
ferentiation. Furthermore, in DLK over-
expressing cells, (i) ERK was phospho-
rylated and (ii) inhibition of MEK1 with 
PD98059 resulted in decreased ERK 
phosphorylation, decreased phospho-
HSP27, decreased association of 
HSP27 with the cytoskeletal fraction, 
and decreased subcortical IF membrane 
localization of HSP27.
Collectively, these observations 
implicate DLK-ERK-HSP27 signaling in 
keratinocyte terminal differentiation and 
suggest that HSP27 may have a role in 
the reorganization of the cytoskeleton 
and/or formation of the cornified enve-
lope. Further questions to be addressed 
in future studies include (i) defining 
additional components of this signaling 
pathway, including upstream activators, 
(ii) identifying the component(s) of the 
detergent insoluble fraction with which 
HSP27 associates during terminal dif-
ferentiation, and (iii) characterizing the 
mechanism by which HSP27 contributes 
to ensuing protein structural transitions. 
Regardless, the study by Robitaille and 
although other kinases have been impli-
cated as HSP27 kinases, including MK3 
and MK5 (PRAK), and these kinases may 
have roles in regulating other HSP27 
functions. HSP27 phosphorylation is 
also regulated by the action of cellular 
phosphatases, including protein phos-
phatase 2A (reviewed in Kostenko and 
Moens, 2009).
In this issue, Robitaille and colleagues 
add to the expanding understanding of 
HSP27 functional biology, presenting 
data implicating a role for HSP27 in 
regulating the structural transitions that 
occur during terminal differentiation of 
keratinocytes, leading to formation of 
the cornified envelope. Using a com-
bination of model systems, including 
keratinocyte monolayer cultures and 
tissue-engineered skin equivalents, the 
distribution and phosphorylation status 
of HSP27 were examined. Coupling 
immunofluorescent microscopy with 
phosphospecific HSP27 antibodies, 
they demonstrated increased phospho-
HSP27 in the granular layer of human 
skin. Keratinocyte differentiation may 
be induced by shifts from low to high 
calcium. When intracellular calcium 
levels of cultured keratinoctyes were 
raised by addition of the calcium car-
rier A23187, the association of HSP27 
with the detergent insoluble cytoskel-
etal fraction was noted. Although levels 
of HSP27 were observed to increase in 
total cellular extracts, levels of other 
heat shock proteins including HSP60 
and HSP70 remained the same, indicat-
ing that the observed increase in HSP27 
was not a stress response, but perhaps a 
differentiation-associated event. To the 
investigators, these observations sug-
gested a role for HSP27 in cytoskeletal 
rearrangements during terminal differ-
entiation.
Human skin equivalents reproduce 
features of stratified epithelium, offer-
ing advantages over keratinocyte cul-
tures in studying keratinocyte terminal 
|A role for HSP27 in cytoskeleton reorganization during 
differentiation. 
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Melanoma Molecular Subtypes: 
Unifying and Paradoxical Results
Nancy E. Thomas1, Peter A. Kanetsky2, Colin B. Begg3, Kathleen Conway4 
and Marianne Berwick5
In this issue, Hacker and colleagues provide further evidence that molecular sub-
types of malignant melanoma may develop along divergent pathways. The authors 
did not find an association between somatic BRAF-mutant melanoma and germline 
melanocortin-1 receptor (MC1R) gene status. We discuss this seeming paradox in 
light of previous studies demonstrating strong associations.
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Introduction
In this issue, Hacker et al. contribute 
new data indicating how BRAF-mutant 
melanomas can be included in their 
previously proposed divergent pathway 
model for melanoma development. Their 
findings lend support to BRAF-mutant 
melanomas developing along a pathway 
positively associated with young age at 
diagnosis, high nevus counts, contigu-
ous nevus remnants, and ability to tan, 
and inversely associated with evidence 
of high level of lifetime cumulative 
sun exposure. However, the authors 
found no association between germline 
melanocortin-1 receptor (MC1R) status 
and BRAF-mutant melanomas in an 
Australian population-based study. These 
results differ from two earlier publica-
tions (Fargnoli et al., 2008; Landi et al., 
2006) that reported strong associations 
in three independent populations (two 
from Italy and one from San Francisco).
Divergent pathways
The results of Hacker et al. (2010, this 
issue) are concordant with many other 
studies that have demonstrated dis-
tinct risk factors for melanomas harbor-
ing BRAF mutations. Both hospital and 
population-based studies on different 
continents have found BRAF mutations to 
be associated with young age at diagno-
sis (Edlundh-Rose et al., 2006; Liu et al., 
2007; Thomas et al., 2007). Others have 
reported that BRAF-melanomas were 
associated with contiguous nevus rem-
nants on histologic sections (Edlundh-
Rose et al., 2006; Poynter et al., 2006). 
Similar to the findings of Hacker et al. 
(2010), BRAF-mutant melanomas have 
been reported to be associated with high 
back nevus counts and increased ability to 
tan in a North Carolina population-based 
study (Thomas et al., 2007). Other studies 
have found BRAF-mutant melanomas to 
be inversely associated with chronically 
exposed anatomic site and solar elastosis, 
providing further evidence of an inverse 
association with high levels of cumulative 
sun exposure (Curtin et al., 2005).
Paradox and possible explanations
Hacker et al. (2010) report no association 
between germline MC1R variants and 
BRAF-mutant melanomas in 123 cases 
from Australia. Similarly, we examined 
the relationship between MC1R status 
and BRAF-mutant melanomas in our 
North Carolina population-based study, 
and, like those of Hacker and colleagues, 
our results do not support a strong asso-
ciation (unpublished data). In contrast, 
Landi et al. (2006) scored independent 
sets of 86 and 112 melanoma specimens 
from a case–control study in Italy and a 
hospital-based series in San Francisco 
for histologic evidence of chronic sun 
damage (CSD). The majority, 56 and 
58, respectively, did not show CSD. 
They reported that MC1R variants were 
strongly associated with BRAF-mutant 
melanomas in biopsies with little histo-
logic evidence of chronic sun damage 
(non-CSD) (Landi et al., 2006). More 
recently, in a separate case–control study 
in Italy that included 92 melanomas 
typed for BRAF mutations, Fargnoli et al. 
(2008) also reported germline MC1R vari-
ants to be strongly associated with BRAF-
mutations, independent of CSD status.
There are several possible explana-
tions for the different results among these 
studies. First, dissimilar estimates may be 
due, in part, to unique effects of specific 
MC1R variants, the frequencies of which 
differ somewhat among study popula-
tions. Second, there may be unidentified 
genotypic variation among populations 
that affects the association of MC1R 
variants with BRAF-mutant melanoma. 
For example, inherited variants in other 
genes related to pigmentation, tanning 
response, or nevus propensity might 
influence this association. Furthermore, 
environmental differences, in particular 
ambient sun exposure, could affect the 
relationship.
Gene–environment and gene–gene 
interactions involving MC1R could be 
